BRCA1 Peptide

Catalog Number

350522

Unit

0.1 mg

Price

$50.00

Description

Breast cancer type 1 susceptibility protein (BRCA1) plays a central role in DNA repair by facilitating cellular response to DNA repair. BRCA1 is required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. BRCA1 is part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. Defects in BRCA1 are a cause of genetic susceptibility to breast and ovarian cancers.

Format

Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.

Data and Images

Product Citations

Recommended Products


200160 BRCA1 Antibody

Alternate Names

Breast cancer type 1 susceptibility protein; RING finger protein 53; BRCA1; RNF53

Accession No.

P38398
NP_009225

MW

2141.3 g/mol

Sequence

The synthetic peptide used to raise the antibody Cat. No. 200160 is selected from a sequence within the N-term region of human BRCA1. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.

Composition

C88H149N29O31S1

Purity

Purity > 80% by HPLC

Solubility

Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.

Storage

Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.

For research use only, not for diagnostic or therapeutic procedures.